Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Equity Ratio (2016 - 2025)

Historic Equity Ratio for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to 0.75.

  • AtriCure's Equity Ratio fell 81.55% to 0.75 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.75, marking a year-over-year decrease of 81.55%. This contributed to the annual value of 0.76 for FY2024, which is 36.81% down from last year.
  • AtriCure's Equity Ratio amounted to 0.75 in Q3 2025, which was down 81.55% from 0.76 recorded in Q2 2025.
  • AtriCure's 5-year Equity Ratio high stood at 0.8 for Q3 2021, and its period low was 0.55 during Q2 2021.
  • For the 5-year period, AtriCure's Equity Ratio averaged around 0.75, with its median value being 0.77 (2024).
  • In the last 5 years, AtriCure's Equity Ratio tumbled by 720.73% in 2021 and then skyrocketed by 4155.49% in 2022.
  • Quarter analysis of 5 years shows AtriCure's Equity Ratio stood at 0.79 in 2021, then decreased by 0.77% to 0.78 in 2022, then fell by 2.67% to 0.76 in 2023, then dropped by 0.37% to 0.76 in 2024, then decreased by 0.88% to 0.75 in 2025.
  • Its Equity Ratio stands at 0.75 for Q3 2025, versus 0.76 for Q2 2025 and 0.77 for Q1 2025.